PROVIDER PROFILE · NPI 1023509866

Laura GurenlianDO

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$86

Distinct drugs

Brand share

0.0%

Top prescribed drugs

QUALITY · MIPS · 2024

Final MIPS score

86.2

Quality

75.4

Cost

75.3

Improvement activities

40.0

Promoting interop.

84.0

Payment adjustment

0.47%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

Hospital

Hospital

CROSS-REFERENCE